Seasonal Influenza Vaccination Resources for Health Professionals

CDC’s Advisory Committee on Immunization Practices (ACIP) voted on June 22, 2022, to preferentially recommend the use of higher dose (including high-dose and recombinant) or adjuvanted flu vaccines over standard-dose unadjuvanted flu vaccines for adults 65 years and older. The recommendation must be approved by the CDC Director before it becomes CDC policy. Updates to this page are forthcoming pending finalization of the recommendation. More information can be found online: Flu Vaccines Worked Better than Initially Estimated this Past Season & CDC’s Advisory Council Recommends Specific Flu Vaccines for Seniors

team of confident medical experts with protective face masks

People with egg allergies can receive any licensed, recommended age-appropriate influenza vaccine (IIV4, RIV4, or LAIV4) that is otherwise appropriate. People who have a history of severe egg allergy (those who have had any symptom other than hives after exposure to egg) should be vaccinated in a medical setting, supervised by a health care provider who is able to recognize and manage severe allergic reactions. Two completely egg-free (ovalbumin-free) flu vaccine options are available: quadrivalent recombinant vaccine and quadrivalent cell-based vaccine.